These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

425 related articles for article (PubMed ID: 14753741)

  • 1. Isolation of a human homolog of osteoclast inhibitory lectin that inhibits the formation and function of osteoclasts.
    Hu YS; Zhou H; Myers D; Quinn JM; Atkins GJ; Ly C; Gange C; Kartsogiannis V; Elliott J; Kostakis P; Zannettino AC; Cromer B; McKinstry WJ; Findlay DM; Gillespie MT; Ng KW
    J Bone Miner Res; 2004 Jan; 19(1):89-99. PubMed ID: 14753741
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel osteoblast-derived C-type lectin that inhibits osteoclast formation.
    Zhou H; Kartsogiannis V; Hu YS; Elliott J; Quinn JM; McKinstry WJ; Gillespie MT; Ng KW
    J Biol Chem; 2001 May; 276(18):14916-23. PubMed ID: 11278931
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Osteoclast inhibitory lectin, a family of new osteoclast inhibitors.
    Zhou H; Kartsogiannis V; Quinn JM; Ly C; Gange C; Elliott J; Ng KW; Gillespie MT
    J Biol Chem; 2002 Dec; 277(50):48808-15. PubMed ID: 12374791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estrogen and testosterone use different cellular pathways to inhibit osteoclastogenesis and bone resorption.
    Michael H; Härkönen PL; Väänänen HK; Hentunen TA
    J Bone Miner Res; 2005 Dec; 20(12):2224-32. PubMed ID: 16294275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Osteoclast inhibitory lectin (OCIL) inhibits osteoblast differentiation and function in vitro.
    Nakamura A; Ly C; Cipetić M; Sims NA; Vieusseux J; Kartsogiannis V; Bouralexis S; Saleh H; Zhou H; Price JT; Martin TJ; Ng KW; Gillespie MT; Quinn JM
    Bone; 2007 Feb; 40(2):305-15. PubMed ID: 17049328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Secreted frizzled-related protein-1 inhibits RANKL-dependent osteoclast formation.
    Häusler KD; Horwood NJ; Chuman Y; Fisher JL; Ellis J; Martin TJ; Rubin JS; Gillespie MT
    J Bone Miner Res; 2004 Nov; 19(11):1873-81. PubMed ID: 15476588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of sugar binding by osteoclast inhibitory lectin.
    Gange CT; Quinn JM; Zhou H; Kartsogiannis V; Gillespie MT; Ng KW
    J Biol Chem; 2004 Jul; 279(28):29043-9. PubMed ID: 15123656
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cloning and identification of human Sca as a novel inhibitor of osteoclast formation and bone resorption.
    Choi SJ; Devlin RD; Menaa C; Chung H; Roodman GD; Reddy SV
    J Clin Invest; 1998 Oct; 102(7):1360-8. PubMed ID: 9769328
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bidirectional signaling between stromal and hemopoietic cells regulates interleukin-1 expression during human osteoclast formation.
    Haynes DR; Atkins GJ; Loric M; Crotti TN; Geary SM; Findlay DM
    Bone; 1999 Sep; 25(3):269-78. PubMed ID: 10495130
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fibroblastic stromal cells express receptor activator of NF-kappa B ligand and support osteoclast differentiation.
    Quinn JM; Horwood NJ; Elliott J; Gillespie MT; Martin TJ
    J Bone Miner Res; 2000 Aug; 15(8):1459-66. PubMed ID: 10934644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Knockout of the murine prostaglandin EP2 receptor impairs osteoclastogenesis in vitro.
    Li X; Okada Y; Pilbeam CC; Lorenzo JA; Kennedy CR; Breyer RM; Raisz LG
    Endocrinology; 2000 Jun; 141(6):2054-61. PubMed ID: 10830290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aging increases stromal/osteoblastic cell-induced osteoclastogenesis and alters the osteoclast precursor pool in the mouse.
    Cao JJ; Wronski TJ; Iwaniec U; Phleger L; Kurimoto P; Boudignon B; Halloran BP
    J Bone Miner Res; 2005 Sep; 20(9):1659-68. PubMed ID: 16059637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin-33 is expressed in differentiated osteoblasts and blocks osteoclast formation from bone marrow precursor cells.
    Schulze J; Bickert T; Beil FT; Zaiss MM; Albers J; Wintges K; Streichert T; Klaetschke K; Keller J; Hissnauer TN; Spiro AS; Gessner A; Schett G; Amling M; McKenzie AN; Horst AK; Schinke T
    J Bone Miner Res; 2011 Apr; 26(4):704-17. PubMed ID: 20939024
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Basic fibroblast growth factor inhibits osteoclast-like cell formation.
    Jimi E; Shuto T; Ikebe T; Jingushi S; Hirata M; Koga T
    J Cell Physiol; 1996 Aug; 168(2):395-402. PubMed ID: 8707875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thiazolidinediones inhibit osteoclast-like cell formation and bone resorption in vitro.
    Okazaki R; Toriumi M; Fukumoto S; Miyamoto M; Fujita T; Tanaka K; Takeuchi Y
    Endocrinology; 1999 Nov; 140(11):5060-5. PubMed ID: 10537132
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of geranylgeranoic acid in bone: induction of osteoblast differentiation and inhibition of osteoclast formation.
    Wang X; Wu J; Shidoji Y; Muto Y; Ohishi N; Yagi K; Ikegami S; Shinki T; Udagawa N; Suda T; Ishimi Y
    J Bone Miner Res; 2002 Jan; 17(1):91-100. PubMed ID: 11771673
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isolation and characterization of osteoclast precursors that differentiate into osteoclasts on calvarial cells within a short period of time.
    Tsurukai T; Takahashi N; Jimi E; Nakamura I; Udagawa N; Nogimori K; Tamura M; Suda T
    J Cell Physiol; 1998 Oct; 177(1):26-35. PubMed ID: 9731742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostaglandin E2, interleukin 1alpha, and tumor necrosis factor-alpha increase human osteoclast formation and bone resorption in vitro.
    Lader CS; Flanagan AM
    Endocrinology; 1998 Jul; 139(7):3157-64. PubMed ID: 9645689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decoy receptor 3 (DcR3) induces osteoclast formation from monocyte/macrophage lineage precursor cells.
    Yang CR; Wang JH; Hsieh SL; Wang SM; Hsu TL; Lin WW
    Cell Death Differ; 2004 Jul; 11 Suppl 1():S97-107. PubMed ID: 15002040
    [TBL] [Abstract][Full Text] [Related]  

  • 20. T-cells mediate an inhibitory effect of interleukin-4 on osteoclastogenesis.
    Mirosavljevic D; Quinn JM; Elliott J; Horwood NJ; Martin TJ; Gillespie MT
    J Bone Miner Res; 2003 Jun; 18(6):984-93. PubMed ID: 12817750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.